Panagiotis Anagnostis

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 893 citations · Full text

Translational Medicine, Parathyroid Hormone, Pharmacology +14

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

Vasilios G. Athyros, Thomas Gossios, Theodora Griva et al. · The Lancet · 2010 · 676 citations

Thrombosis, Greek Atorvastatin, Cardiovascular Disease +11

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions

Panagiotis Anagnostis, John C. Stevenson, David Crook et al. · Maturitas · 2015 · 171 citations

Metabolic Syndrome, Lipid Disorder, Aging +11

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

Petros Perros, László Hegedüs, Luigi Bartalena et al. · Orphanet Journal of Rare Diseases · 2017 · 168 citations · Full text